Skip to main content
Clinical Trials/NCT01942759
NCT01942759
Completed
Not Applicable

The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Detection of Primary Tumor and Axillary Metastasis for Breast Cancer: SUVMax Against to ADC

Bagcilar Training and Research Hospital1 site in 1 country43 target enrollmentSeptember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Neoplasms
Sponsor
Bagcilar Training and Research Hospital
Enrollment
43
Locations
1
Primary Endpoint
To evaluate the relationships between both SUVmax and ADC and clinicopathological prognostic factors
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine findings of positron emission tomography and diffusion weighted magnetic resonance in primary lesion and axillary metastasis of breast cancer and compare of two imaging modality in these patients.

Detailed Description

We aimed that to correlate both primary lesion 18F-fluorodeoxyglucose (FDG) maximum standardized uptake value (SUVmax) and diffusion-weighted imaging (DWI) apparent diffusion coefficient (ADC) with clinicopathological prognostic factors and compare the prognostic value of these indexes in breast cancer in this study. The evaluated and compared parameters are SUVmax and ADC according to age, tumour size, lymph node metastasis, receptor status, histologic grade, modified Nottingham prognostic index.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
June 2014
Last Updated
11 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Bagcilar Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Aynur Ozen

Aynur Ozen

Bagcilar Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosis of breast cancer for which surgical intervention is planned

Exclusion Criteria

  • patients received neoadjuvant chemotherapy
  • before breast surgery

Outcomes

Primary Outcomes

To evaluate the relationships between both SUVmax and ADC and clinicopathological prognostic factors

Time Frame: 3 years

Study Sites (1)

Loading locations...

Similar Trials